Questions? Contact Pharmacy Management at (855) 305-5062 | TTY/TDD (877) 652-1844
For free translation service, call (800) 892-0675
HP-3340 10-19
Clinical Information Submitted for Determination
To provide required information, attach additional sheets, lab results, and other supporting documentation
as necessary. Denote which pages of the records to review to help expedite the review process.
Preterm Infants without Chronic Lung Disease of Prematurity or Congenital Heart Disease
Risk factors?
☐
Young chronological age < 12 weeks
☐ Severe neuromuscular disease
☐ Congenital abnormality of the airway
☐
Exposure to environmental air pollutants
☐
Preschool or school aged siblings
☐ Daycare attendance outside the home
☐ RSV activity per CDC National Respiratory
and Enteric Virus Surveillance System > 10 %
Provide a letter of medical necessity from two (2) of the following three
(3) subspecialties:
1. Pediatric Infectious Disease 2. Neonatology 3. Pediatric Pulmonology
Attach Documentation
Preterm Infants with Chronic Lung Disease of Prematurity
Did the infant require > 21 % oxygen for at least the first 28 days after
birth?
☐
☐ No
If yes, provide clinical documentation to support the use of > 21 %
oxygen for at least the first 28 days after birth.
Attach Documentation
In the past 6 months, has the infant required any of the following: chronic
corticosteroid therapy, diuretic therapy, or supplemental oxygen?
☐
☐ No
If yes, provide clinical documentation or pharmacy records to
support the use of one or more of the above.
Attach Documentation
Infants with hemodynamically significant congenital heart disease (CHD)
List medication(s) infant is on to control congestive heart failure or
pulmonary hypertension.
Will the infant require cardiac surgical procedures?
☐
☐
Does the infant have moderate-to-severe pulmonary hypertension?
☐
☐
Has or will the infant undergo cardiac transplantation during the RSV
season?
☐
☐ No
Provide a letter of medical necessity from a pediatric cardiologist. Attach Documentation
Children with anatomic pulmonary abnormalities or neuromuscular disease
Provide clinical documentation that the infant has neuromuscular
disease or congenital abnormality that impairs the ability to clear
secretions from the upper airway.
Attach Documentation
Immunocompromised Children
Provide clinical documentation supporting that the infant is profoundly
immunocompromised.
Attach Documentation
Children with Cystic Fibrosis
In the past 6 months, has the infant required any of the following: chronic
corticosteroid therapy, diuretic therapy, or supplemental oxygen?
☐
☐ No
If yes, provide clinical documentation or pharmacy records to
support the use of one or more of the above.
Attach Documentation
Has the infant been hospitalized in their first year of life for pulmonary
exacerbation?
☐
☐ No
Does the infant have abnormalities on chest radiography or chest
computed tomography that persist when stable?
☐
☐ No
Is the infant’s weight less than the 10
th
percentile?
☐
☐
Prescriber signature (same as prescriber listed above):